S-Propargyl-cysteine (SPRC), a substrate of cystathionine γ-lyase (CSE), is a water-soluble modulator of endogenous hydrogen disulfide (H2S). SPRC is a potential agent for the treatment of Alzheimer’s disease (TNF signalling, the NF-κB pathway and the ERK1/2 pathway), anemia of inflammation (IL-6/JAK2/STAT3 pathway), ischemic heart disease (H2S/VEGFR2/STAT3 pathway) and myocardial infarction.
KEYWORDS: S-Propargyl-Cysteine | supplier | H2S donor | SPRC | ZYZ-802 | S-Propargylcysteine | ZYZ802 | ZYZ 802 | CAS [3262-64-4] | L-cysteine | CSE | Activator | Enzymes